R G Cohen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
R G Cohen has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Mark L. Barr
University of Southern California, Los Angeles, CA, USA
3 shared publications - V A Starnes
Department of Cardiothoracic Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA
3 shared publications C C Marboe
1 shared publicationF A Schenkel
1 shared publicationK M Chan
1 shared publicationR G Barbers
1 shared publication
Latest Publications
- 24 February 2001
- Published by Wiley in World Journal of Surgery
- Vol. 25 (2) , 244-250
Living Donor Lung Transplantation
Since 1993 a total of 101 living‐donor bilateral lung transplants have been performed with acceptable results when compared with those utilizing cadaveric lung grafts. Though most recipients were patients with cystic fibrosis who were rapidly deteriorating, the indications for livedonor lung transplantation have been expanded to include some cystic fibrosis patients in a more elective setting, as well as select patients with other end‐stage pulmonary diseases. One‐year Kaplan‐Meier recipient survival is 72%. Seventy‐six percent of deaths occur within the first 2 months after transplantation. The most common cause of death is infection, which accounts for 62% of the 1‐year mortality rate. The incidence of rejection is 0.8 episodes per patient. Thirty percent of rejection episodes are unilateral, and most tend to be mild. Altogether, 203 patients have undergone donor lobectomy, with a mean age of 37 ± 12 years (range 18–56 years). Operations included left lower lobectomy (102 patents), right lower lobectomy (97 patients), and right middle and lower lobectomy (4 patients). There has been no donor mortality. Postoperative Rand 36 Question Quality of Life scores, rating physical function, social functioning, and role limitation due to physical and emotional health, are well over 92 (of a possible score of 100). Eighty‐five percent of donors said that their health was no different or improved since donation.
- 24 February 2001
- Published by Wiley in World Journal of Surgery
- Vol. 25 (2) , 244-250
Living Donor Lung Transplantation
Since 1993 a total of 101 living‐donor bilateral lung transplants have been performed with acceptable results when compared with those utilizing cadaveric lung grafts. Though most recipients were patients with cystic fibrosis who were rapidly deteriorating, the indications for livedonor lung transplantation have been expanded to include some cystic fibrosis patients in a more elective setting, as well as select patients with other end‐stage pulmonary diseases. One‐year Kaplan‐Meier recipient survival is 72%. Seventy‐six percent of deaths occur within the first 2 months after transplantation. The most common cause of death is infection, which accounts for 62% of the 1‐year mortality rate. The incidence of rejection is 0.8 episodes per patient. Thirty percent of rejection episodes are unilateral, and most tend to be mild. Altogether, 203 patients have undergone donor lobectomy, with a mean age of 37 ± 12 years (range 18–56 years). Operations included left lower lobectomy (102 patents), right lower lobectomy (97 patients), and right middle and lower lobectomy (4 patients). There has been no donor mortality. Postoperative Rand 36 Question Quality of Life scores, rating physical function, social functioning, and role limitation due to physical and emotional health, are well over 92 (of a possible score of 100). Eighty‐five percent of donors said that their health was no different or improved since donation.
- 1 June 1995
- Vol. 27 (3) , 1995-6
Living-related lobar transplantation: recipient outcome and early rejection patterns.
- 1 June 1995
- Vol. 27 (3) , 1995-6
Living-related lobar transplantation: recipient outcome and early rejection patterns.
- 1 September 1994
- Vol. 108 (3) , 403
Lobar transplantation. Indications, technique, and outcome.
Lobar transplantation represents a therapeutic option for children and some adults with severe end-stage pulmonary disease. Six patients including two neonates, three children, and one adult underwent lobar transplantation. Ages ranged from 17 days to 21 years. Transplant procedures were unilateral in the neonates and two of the children and bilateral in the child and adult who had cystic fibrosis. The donor lobes were from cadavers in the two neonates and living related donors in the children and the adult. Unilateral grafts involved use of the right upper lobe in the 12-year-old patient with bronchopulmonary dysplasia; right middle lobe with a ventricular septal defect repair in the 4-year-old patient with Eisenmenger's syndrome, left upper lobe in the 28-day-old patient with primary pulmonary hypertension, and the right upper and middle lobes in the 17-day-old patient with diaphragmatic hernia. Bilateral lobar transplantations were performed with the right lower and left lower lobes in the two patients with cystic fibrosis (aged 13 and 21 years). The two neonates underwent emergency transplantation with the use of extracorporeal membrane oxygenation as a bridge. Perioperative survival was 83%, with only the 4-year-old patient with ventricular septal defect/Eisenmenger's syndrome dying early. No airway complications were observed. The unilateral grafts received most of the blood flow as shown by perfusion scanning (range 74% to 99%). Living related donor complications included prolonged air leaks (> 6 days) in two patients. In urgent situations, such as an infant requiring extracorporeal membrane oxygenation, and in the existing milieu of donor shortage, lobar transplantation (living related or cadaveric) is a surgically feasible procedure and can provide a donor source in the limited time frame of these clinical situations. Bilateral lobe transplantation may be a viable option for patients with cystic fibrosis and life-threatening respiratory decompensation.
- 1 September 1994
- Vol. 108 (3) , 403
Lobar transplantation. Indications, technique, and outcome.
Lobar transplantation represents a therapeutic option for children and some adults with severe end-stage pulmonary disease. Six patients including two neonates, three children, and one adult underwent lobar transplantation. Ages ranged from 17 days to 21 years. Transplant procedures were unilateral in the neonates and two of the children and bilateral in the child and adult who had cystic fibrosis. The donor lobes were from cadavers in the two neonates and living related donors in the children and the adult. Unilateral grafts involved use of the right upper lobe in the 12-year-old patient with bronchopulmonary dysplasia; right middle lobe with a ventricular septal defect repair in the 4-year-old patient with Eisenmenger's syndrome, left upper lobe in the 28-day-old patient with primary pulmonary hypertension, and the right upper and middle lobes in the 17-day-old patient with diaphragmatic hernia. Bilateral lobar transplantations were performed with the right lower and left lower lobes in the two patients with cystic fibrosis (aged 13 and 21 years). The two neonates underwent emergency transplantation with the use of extracorporeal membrane oxygenation as a bridge. Perioperative survival was 83%, with only the 4-year-old patient with ventricular septal defect/Eisenmenger's syndrome dying early. No airway complications were observed. The unilateral grafts received most of the blood flow as shown by perfusion scanning (range 74% to 99%). Living related donor complications included prolonged air leaks (> 6 days) in two patients. In urgent situations, such as an infant requiring extracorporeal membrane oxygenation, and in the existing milieu of donor shortage, lobar transplantation (living related or cadaveric) is a surgically feasible procedure and can provide a donor source in the limited time frame of these clinical situations. Bilateral lobe transplantation may be a viable option for patients with cystic fibrosis and life-threatening respiratory decompensation.
- 1 November 1993
- Vol. 2 (4) , 279-88
Pediatric lung transplantation.
As the first decade of successful clinical lung transplantation draws to a close, the number of patients who are able to benefit from it continues to increase. Pulmonary transplantation in the pediatric age group is possible for an expanding range of diagnoses currently known to cause end-stage lung disease. However, more experience will be required before the answers to a number of clinical problems are found. The following issues are particularly pertinent to the pediatric age group: (1) Controversy still exists as to the most appropriate operation for certain clinical situations (eg, single- or double-lung transplants for primary pulmonary hypertension, or secondary pulmonary hypertension after cardiac repair). These decisions are made based on physiological considerations as well as donor availability and the need to use the donor pool as efficiently as possible. (2) Technical controversies in pediatric lung transplantation include the optimal technique for performing the bronchial anastomosis in a manner that will permit healing without stenosis of the airway. Cardiopulmonary bypass is required for most lung transplants in children. (3) OB continues to plague the long-term results of lung transplantation and may be more common in the pediatric age group. OB may respond to increased immunosuppression. (4) Lobar transplantation in children may be an effective method of increasing the availability of donors. More experience will be necessary to further refine this technique.
- 1 November 1993
- Vol. 2 (4) , 279-88
Pediatric lung transplantation.
As the first decade of successful clinical lung transplantation draws to a close, the number of patients who are able to benefit from it continues to increase. Pulmonary transplantation in the pediatric age group is possible for an expanding range of diagnoses currently known to cause end-stage lung disease. However, more experience will be required before the answers to a number of clinical problems are found. The following issues are particularly pertinent to the pediatric age group: (1) Controversy still exists as to the most appropriate operation for certain clinical situations (eg, single- or double-lung transplants for primary pulmonary hypertension, or secondary pulmonary hypertension after cardiac repair). These decisions are made based on physiological considerations as well as donor availability and the need to use the donor pool as efficiently as possible. (2) Technical controversies in pediatric lung transplantation include the optimal technique for performing the bronchial anastomosis in a manner that will permit healing without stenosis of the airway. Cardiopulmonary bypass is required for most lung transplants in children. (3) OB continues to plague the long-term results of lung transplantation and may be more common in the pediatric age group. OB may respond to increased immunosuppression. (4) Lobar transplantation in children may be an effective method of increasing the availability of donors. More experience will be necessary to further refine this technique.